Exelixis Stock Current Liabilities
EXEL Stock | USD 21.06 0.15 0.72% |
Exelixis fundamentals help investors to digest information that contributes to Exelixis' financial success or failures. It also enables traders to predict the movement of Exelixis Stock. The fundamental analysis module provides a way to measure Exelixis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Exelixis stock.
At this time, Exelixis' Total Current Liabilities is quite stable compared to the past year. Non Current Liabilities Other is expected to rise to about 98.9 M this year, although the value of Non Current Liabilities Total will most likely fall to about 213.1 M. Exelixis | Current Liabilities |
Exelixis Company Current Liabilities Analysis
Exelixis' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Exelixis Current Liabilities | 52.25 M |
Most of Exelixis' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Exelixis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Exelixis Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Exelixis is extremely important. It helps to project a fair market value of Exelixis Stock properly, considering its historical fundamentals such as Current Liabilities. Since Exelixis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Exelixis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Exelixis' interrelated accounts and indicators.
Click cells to compare fundamentals
Exelixis Current Liabilities Historical Pattern
Today, most investors in Exelixis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Exelixis' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Exelixis current liabilities as a starting point in their analysis.
Exelixis Current Liabilities |
Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
Exelixis Liabilities And Stockholders Equity
Liabilities And Stockholders Equity |
|
In accordance with the recently published financial statements, Exelixis has a Current Liabilities of 52.25 M. This is 97.02% lower than that of the Biotechnology sector and 90.38% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.34% higher than that of the company.
Exelixis Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Exelixis' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Exelixis could also be used in its relative valuation, which is a method of valuing Exelixis by comparing valuation metrics of similar companies.Exelixis is currently under evaluation in current liabilities category among related companies.
Exelixis ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Exelixis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Exelixis' managers, analysts, and investors.Environmental | Governance | Social |
Exelixis Fundamentals
Return On Equity | 0.0876 | ||||
Return On Asset | 0.043 | ||||
Profit Margin | 0.11 % | ||||
Operating Margin | 0.15 % | ||||
Current Valuation | 5.37 B | ||||
Shares Outstanding | 291.29 M | ||||
Shares Owned By Insiders | 2.22 % | ||||
Shares Owned By Institutions | 89.12 % | ||||
Number Of Shares Shorted | 9.57 M | ||||
Price To Earning | 48.17 X | ||||
Price To Book | 3.05 X | ||||
Price To Sales | 3.78 X | ||||
Revenue | 1.83 B | ||||
Gross Profit | 1.55 B | ||||
EBITDA | 196.6 M | ||||
Net Income | 207.76 M | ||||
Cash And Equivalents | 1.53 B | ||||
Cash Per Share | 4.77 X | ||||
Total Debt | 189.94 M | ||||
Debt To Equity | 0.07 % | ||||
Current Ratio | 6.08 X | ||||
Book Value Per Share | 7.21 X | ||||
Cash Flow From Operations | 333.32 M | ||||
Short Ratio | 4.98 X | ||||
Earnings Per Share | 0.65 X | ||||
Price To Earnings To Growth | 1.69 X | ||||
Target Price | 26.55 | ||||
Number Of Employees | 1.31 K | ||||
Beta | 0.57 | ||||
Market Capitalization | 6.13 B | ||||
Total Asset | 2.94 B | ||||
Retained Earnings | (173.35 M) | ||||
Working Capital | 923.68 M | ||||
Current Asset | 178.66 M | ||||
Current Liabilities | 52.25 M | ||||
Net Asset | 2.94 B |
About Exelixis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Exelixis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Exelixis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Exelixis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Exelixis using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Exelixis Piotroski F Score and Exelixis Altman Z Score analysis. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.Note that the Exelixis information on this page should be used as a complementary analysis to other Exelixis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Exelixis Stock analysis
When running Exelixis' price analysis, check to measure Exelixis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exelixis is operating at the current time. Most of Exelixis' value examination focuses on studying past and present price action to predict the probability of Exelixis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exelixis' price. Additionally, you may evaluate how the addition of Exelixis to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Stocks Directory Find actively traded stocks across global markets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Exelixis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.65 | Revenue Per Share 5.914 | Quarterly Revenue Growth 0.04 | Return On Assets 0.043 | Return On Equity 0.0876 |
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.